Durect Corp Asset Turnover Ratio (DRRX), as of second quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Durect Corp  (NASDAQ: DRRX)
 

Durect Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Durect's asset turnover ratio, the ratio that measures the ability of Durect's assets to generate revenue, sequentially decreased to 0.16 in the second quarter (Jun 30 2025), but it does not raise any concerns as Durect continue to execute well, and the asset turnover ratio remains above the average.

Within sector Durect Corp achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition



DRRX Asset Turnover Ratio (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
Y / Y Asset Change -53.79 % -57.19 % -60.33 % -57.45 % -43.82 %
Y / Y Revenue Change -79.41 % -82.43 % - 10.49 % 4.32 %
Asset Turnover Ratio (TTM) 0.16 0.22 - 0.27 0.22
DRRX's Total Ranking # # # # #
Seq. Asset Change -11.82 % -16.18 % -21.59 % -20.27 % -18.31 %
Seq. Revenue Change 39.25 % - - -11.24 % 18.83 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Zimvie Inc   0.58 $ 443.402  Millions$ 760.157  Millions
Merit Medical Systems Inc  0.58 $ 1,433.025  Millions$ 2,462.676  Millions
Guardant Health Inc   0.58 $ 828.849  Millions$ 1,425.140  Millions
Cumberland Pharmaceuticals Inc   0.58 $ 42.072  Millions$ 72.543  Millions
Provectus Biopharmaceuticals Inc   0.58 $ 0.460  Millions$ 0.799  Millions
Solventum Corporation  0.58 $ 8,388.000  Millions$ 14,572.250  Millions
Ani Pharmaceuticals Inc  0.57 $ 747.399  Millions$ 1,301.626  Millions
Pulmonx Corporation  0.57 $ 90.162  Millions$ 157.044  Millions
Conmed Corporation  0.57 $ 1,326.246  Millions$ 2,312.033  Millions
Alnylam Pharmaceuticals Inc   0.57 $ 2,461.963  Millions$ 4,306.213  Millions
Iqvia Holdings Inc   0.57 $ 15,700.000  Millions$ 27,508.250  Millions
Emmaus Life Sciences Inc   0.57 $ 13.792  Millions$ 24.192  Millions
Bruker Corporation  0.57 $ 3,441.500  Millions$ 6,048.125  Millions
Radnet Inc   0.57 $ 1,907.872  Millions$ 3,353.316  Millions
Ethema Health Corporation   0.57 $ 11.650  Millions$ 20.479  Millions
Procept Biorobotics Corporation  0.57 $ 275.490  Millions$ 485.147  Millions
Icu Medical Inc  0.56 $ 2,371.547  Millions$ 4,200.235  Millions
Agilent Technologies inc   0.56 $ 6,774.000  Millions$ 12,019.000  Millions
Halozyme Therapeutics Inc   0.56 $ 1,178.672  Millions$ 2,107.985  Millions
Sight Sciences Inc   0.56 $ 75.149  Millions$ 134.522  Millions
Haemonetics Corporation  0.56 $ 1,345.278  Millions$ 2,408.464  Millions
Avanos Medical Inc   0.56 $ 690.400  Millions$ 1,239.300  Millions
Integer Holdings Corporation  0.55 $ 1,780.251  Millions$ 3,228.565  Millions
Establishment Labs Holdings Inc   0.55 $ 177.289  Millions$ 323.137  Millions
Aytu Biopharma Inc  0.55 $ 65.831  Millions$ 120.109  Millions
Merck and Co Inc   0.54 $ 63,616.000  Millions$ 116,820.750  Millions
Allurion Technologies Inc   0.54 $ 20.184  Millions$ 37.524  Millions
Abbott Laboratories  0.54 $ 43,109.000  Millions$ 80,304.250  Millions
Avantor Inc   0.53 $ 6,665.800  Millions$ 12,514.600  Millions
Steris Plc  0.53 $ 5,571.113  Millions$ 10,464.413  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.